Verition Fund Management LLC Pa Vmed Inc. Transaction History

Verition Fund Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.35 - $0.56 $96,219 - $153,951	-274,913 Reduced 66.09%	141,029 $57,000
Q1 2023 May 15, 2023	BUY	$0.36 - $0.63 $98,968 - $173,195	274,913 Added 194.93%	415,942 $153,000
Q4 2022 Feb 14, 2023	SELL	$0.41 - $18.6 $18,791 - $852,475	-45,832 Reduced 24.53%	141,029 $67,000
Q2 2022 Aug 15, 2022	BUY	$0.85 - $1.41 $32,707 - $54,255	38,479 Added 25.93%	186,861 $175,000
Q1 2022 May 13, 2022	BUY	$1.16 - $2.5 $172,123 - $370,955	148,382 New	148,382 $196,000
Q2 2021 Aug 16, 2021	SELL	$3.95 - $6.88 $256,848 - $447,372	-65,025 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$2.01 - $5.55 $130,700 - $360,888	65,025 New	65,025 $288,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $52.8M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.